| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6194281 | Urologic Oncology: Seminars and Original Investigations | 2014 | 9 Pages |
Abstract
Our results indicate that miR-145 inhibits bladder cancer cell invasion, at least partly through targeting PAK1. Restoration or replacement of miR-145 could be an efficient approach to inhibit PAK1 and bladder cancer development in the tumor therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Bo Ph.D., Yang Ph.D., Chong M.S., Qi Ph.D., Shan M.S., Chen-Qing M.S., Xinyang A.S., Dalin M.D., Peng Ph.D.,